Cytori Therapeutics, a cell therapy company in San Diego, named John D. Harris as vice president and general manager of cell therapy, a newly created role to be based in Tokyo.
In his new post, Harris will focus on growth and development of Cytori’s existing and future global cell therapy commercial operations.
“John is uniquely qualified for this role for a number of reasons, including his demonstrated leadership capabilities, familiarity with the Japanese and Asia-Pacific markets, and his first-hand knowledge of global cell therapy trends and opportunities,” said Marc Hedrick, Cytori’s president and CEO in a statement.
Harris currently heads the Japanese operations of Becton Dickinson and Co., which include a production facility, over 550 employees, and approximately $315 million in revenues. He was previously business director of Becton Dickinson’s medical systems business unit and lead of the preanalytical systems business unit.
His previous positions include Asia medical sales director for the electronics division of Tyco International, global business development manager for Delphi Medical Systems and senior business development manager for medical products at Kimberly-Clark/Ballard.